ReviewFrontiers in pharmacology2019

Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target.

Shengjie Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.